Literature DB >> 24088757

Purulent pericarditis and cardiac tamponade caused by Nocardia farcinica in a nephrotic syndrome patient.

Rujipas Sirijatuphat1, Sorachat Niltwat, Orathai Tiangtam, Wiwun Tungsubutra.   

Abstract

Nocardiosis is an uncommon infection that occurs primarily in immunocompromised patients. We herein report an extremely rare case of Nocardia farcinica (N. farcinica) pericarditis. A 53-year-old man with nephrotic syndrome that required chronic corticosteroid therapy presented with pleuritic chest pain and cardiac tamponade. Pericardiocentesis revealed purulent pericardial effusion and a bacteriological examination showed the characteristic branching filamentous bacteria identified as N. farcinica. Aggressive surgical drainage and a trimethoprim-sulfamethoxazole based regimen resulted in clinical improvement. To the best of our knowledge, this is the first reported case of N. farcinica pericarditis in Thailand.

Entities:  

Mesh:

Year:  2012        PMID: 24088757     DOI: 10.2169/internalmedicine.52.0453

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Cloning, Expression, Invasion, and Immunological Reactivity of a Mammalian Cell Entry Protein Encoded by the mce1 Operon of Nocardia farcinica.

Authors:  Xingzhao Ji; Xiaoluo Tan; Xuexin Hou; Chenchen Si; Shuai Xu; Lu Tang; Xiuqin Yuan; Zhenjun Li
Journal:  Front Microbiol       Date:  2017-02-22       Impact factor: 5.640

2.  Nocardia Infection in Nephrotic Syndrome Patients: Three Case Studies and A Systematic Literature Review.

Authors:  Yan Cheng; Tian-Yi Wang; Hong-Li Yuan; Wei Li; Jing-Ping Shen; Zheng-Xin He; Jing Chen; Jie-Ying Gao; Fu-Kun Wang; Jiang Gu
Journal:  Front Cell Infect Microbiol       Date:  2022-01-24       Impact factor: 5.293

3.  A Rare Presentation of Nocardia pericarditis Leading to Cardiac Tamponade in an Immunocompetent Patient.

Authors:  Erika L Faircloth; Patrick Troy
Journal:  Cureus       Date:  2019-02-26

4.  Nocardiosis in glomerular disease patients with immunosuppressive therapy.

Authors:  Yuzhang Han; Zineng Huang; Huifang Zhang; Liyu He; Lin Sun; Yu Liu; Fuyou Liu; Li Xiao
Journal:  BMC Nephrol       Date:  2020-11-26       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.